ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA approves Kyowa Kirin’s Nourianz drug for Parkinson’s disease
September 03, 2019The US Food and Drug Administration (FDA) has approved Japanese company Kyowa Kirin’s drug Nourianz (istradefylline) as an add-on to the existing drug levodopa/carbidopa to treat adults... -
Kirin Holdings to withdraw from 30 year venture with Amgen, sell shares for $780m
November 01, 2017Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would sell its 50% share in the partnership for $780 million.
Pharma Sources Insight January 2025
